Antares Pharma, Inc. Made Headway

Thu, Apr 14, 2022 at 05:30 PM
Antares Pharma, Inc. Made Headway

Antares Pharma, Inc. (ATRS:NASDAQ) shot up at $5.56, a gain of 48.7%. On Wed, Apr 13, 2022, ATRS:NASDAQ hit a New 2-Week High of $5.58. The stock got featured on our News Catalysts scanner on Thu, Apr 14, 2022 at 01:16 PM in the 'ACQUISITION' category. From Wed, Mar 30, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days

About Antares Pharma, Inc. (ATRS:NASDAQ)

Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.